The effectiveness of simultaneous oncoplastic breast surgery in patients with locally advanced breast cancer

Emiroğlu, Mustafa; Sert, İsmail; Karaalı, Cem; Aksoy, Süleyman Özkan; Uğurlu, Levent; Aydın, Cengiz

doi:10.1007/s12282-015-0585-z

Cited by 24 publications

(26 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The complication rates reported in the literature vary between 10 to 91% in the reduction mammoplasty operations performed for both malignant and benign reasons (8)(9)(10)(11)(12)(13). A recent systematic review of OBCS reported postoperative complications occurred in 14.3% of patients, including liponecrosis 3.3%, skin necrosis 0.5%, hematoma 2.5%, seroma 1.0%, delayed wound healing 2.2%, nipple necrosis 0.4% and/or infection 1.9% (14).…”

Section: Discussionmentioning

confidence: 99%

Early Wound Complications And Influencing Factors For The Breast Cancer Patients After Oncoplastic Surgery

Kızıltan¹,

Özaslan²,

Karaman³

et al. 2018

Acta Oncol Tur.

View full text Add to dashboard Cite

Bu çalışmada meme kanseri tanısı almış ve onkoplastik cerrahi teknikleri ile tedavi edilmiş hastalarda gelişen erken dönem yara komplikasyonları ve bu komplikasyonlara etki eden faktörler araştırılmıştır. YÖNTEM ve GEREÇLER: Superior ve inferior pedikül onkoplastik cerrahi tekniklerinden biri uygulanarak opere edilmiş 77 hastaya ait veriler retrospektif olarak incelendi. Hastalara ait veriler ile yara komplikasyonlarının gelişip gelişmediği kayıt altına alındı. BULGULAR: Yapılan istatistiksel değerlendirmeler sonucunda ileri yaş, hipertansiyon ve doku ağırlığının yara komplikasyon riskini arttırdığı tespit edilmiştir. Çıkarılan doku ağırlığı ve hipertansiyon bağımsız risk faktörü olarak saptanmıştır. Meme kanseri nedeni ile ameliyat edilen hastalardan oluşan serimizde minör komplikasyonlar %23.4 oranında görülmüştür. TARTIŞMA ve SONUÇ: Çalışmamızdaki minor komplikasyon oranı literatürde belirtilmiş komplikasyon oranları ile uyumludur. Hasta yaşı, yara iyileşmesini etkileyen komorbid hastalıklar ve çıkarılan doku hacmi arttıkça komplikasyon oranlarının arttığı bilinmektedir. İleri yaş ve komorbid hastalıkların varlığı komplikasyonları arttıran bir faktör olmakla birlikte ameliyat için kontrendikasyon teşkil etmez.Çalışmamız sonucunda elde ettiğimiz veriler de onkoplastik meme cerrahisinin, meme kanseri olan hastalarda klasik meme koruyucu cerrahi tekniklerinden daha geniş eksizyon imkanı sağladığı ve komplikasyon oranlarını arttırmadan güvenle kullanılabileceğini göstermektedir. Anahtar Kelimeler: meme kanseri, onkoplastik meme cerrahisi, yara komplikasyonları ABSTRACT INTRODUCTION: In this study, early wound complications and factors affecting these complications were investigated in patients diagnosed with breast cancer and treated with oncoplastic surgery techniques. METHODS: The data of 77 patients who underwent surgery with superior or inferior pedicle oncoplastic breast surgery techniques were retrospectively analyzed. The patients' data and the information about wound complications were recorded. RESULTS: As a result of statistical evaluations, it was determined that age, hypertension and removed tissue weight increased the risk of wound complications. The removed tissue weight and hypertension were found to be independent risk factors. In our series, our minor complication rate is 23.4%. DISCUSSION and CONCLUSION: Minor complication rate of our series is similar with the literature. It is known that the complication rates increases with patient age, comorbid diseases and the amount of removed tissue volume. Age and the presence of comorbid diseases are some of the factors that increase complications, but not a contraindication for the surgery. The data obtained from our study showed that; since oncoplastic breast surgery provides wider excision than classical breast-conserving surgical techniques, it can be used safely without increasing complication rates in the patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Early Wound Complications And Influencing Factors For The Breast Cancer Patients After Oncoplastic Surgery

Kızıltan¹,

Özaslan²,

Karaman³

et al. 2018

Acta Oncol Tur.

View full text Add to dashboard Cite

show abstract

“…Mathes et al [18] operated 17 patient with LABC utilizing advanced oncoplastic techniques with no positive margins, Similary Viera et al [16] reported margin length 16.44 mm by oncoplastic surgery with no positive margins, Emiroglu et al [14] found that the mean surgical margin length was 8.7 mm (range 5 -17 mm) with positive margins in 7.1% of cases, in a study done by Clough et al [21] patients who received NACT and OS had a positive margins rate 10.9%.…”

Section: Discussionmentioning

confidence: 99%

“…The mean follow up was 1.7 years with 2 cases had local recurrence (LR) (one had triple negative tumor and the other was Her-2+), Within 61 months follow up Emiroglu et al [14] had 14.6% local recurrence, Regano [19] reported 1 case with LR during 32 months follow up, 2 cases had LR within 60 months follow up in study of Viera [16], Specht and Gralow [15] reported no LR in 15 months follow up, mean follow-up was 72.8 months. Ipsilateral local and locoregional recurrence were 11.2% and 15.3% respectively in the study published by Carrrara in 2017 [13].…”

Section: Discussionmentioning

confidence: 99%

Oncoplastic Breast Surgery after Neoadjuvant Chemotherapy Replacing Mastectomy in Locally Advanced Breast Cancer (LABC): Single Institute Experience

Ghamrini¹,

Morad²,

Elsadek³

et al. 2017

JCT

View full text Add to dashboard Cite

Background: Integration of neoadjuvant chemotherapy (NCT) in early 70s resulted that many LABC tumors become resectable but with total mastectomy especially those with partial response, oncoplastic techniques give better oncological outcome with better cosmetic results. Objective: We evaluate the oncological safety of oncoplastic breast surgery (OS) in LABC showing partial response to NCT. Methods: We prospectively analyzed the data of 32 out of 58 patients with LABC who showed partial response to NCT and could have conservative surgery with advanced oncoplastic techniques rather than total mastectomy. Results: Out of 58 patients with LABC, received neoadjuvant chemotherapy, complete response was observed in 8 patients (13%), partial response reported in 32 (55.1%) cases, 12 patients (20%) had stable disease and 6 patients (10%) showed progressive disease. Data of 32 cases were studied (mean age 44.84 ± 9.10 years; range 26 -59 years). Inferior pedicle was performed in 9 cases, mini LD flap in 3 patients, 5 had Grissotti technique, 6 with superomedial pedicle, 4 had V mammoplasty and 3 with J mammoplasty and 2 had vertical mammoplasty. Margins were positive in 5 cases (15.6%) with mean margin width 9.63 ± 5.72 (range 0 -22 mm), and the local recurrence was reported in 2 cases (6.2%). Complications were reported in 3 cases (9.3%). The follow up was 1.67 ± 1.03 (range 0 -3.3 years). Conclusions: Integration of neoadjuvant chemotherapy together with advanced oncoplastic techniques opens a new way for management of LABC especially those showing partial response with avoidance of total mastectomy, and comparable oncological safety in addition to better aesthetic and psychological outcome.

show abstract

“…If the skin is closed directly, breast deformity or dislocation of the nipple-areolar complex may occur (8). Oncoplastic surgical techniques are necessary to achieve good cosmetic outcomes from BCS (8,9).…”

Section: Introductionmentioning

confidence: 99%

Application of a rhomboid flap for the coverage of defects after malignant breast tumor resection: A case report

et al. 2017

View full text Add to dashboard Cite

Abstract. Resection for locally advanced breast cancer (LABC) or malignant phyllodes tumors may cause a large skin defect with bone exposure. Although skin grafts are frequently used to cover such defects, they can result in poor cosmetic outcomes and graft acceptance is dependent upon the condition of the recipient site. To overcome the limitations of skin grafts, various flaps have been developed to cover such defects. The present study used a rhomboid flap for the coverage of skin defects after mastectomy and breast-conservative surgery (BCS). A total of 11 patients with malignant breast cancer underwent reconstructive surgery using the rhomboid flap between September 2011 and December 2013 (mastectomy, 9 patients; BCS, 2 patients). Skin resection size, axillary lymph node dissection, bone exposure, length of surgery, wound complications and whether preoperative/postoperative adjuvant therapy was received were analyzed. The maximum size of skin defect covered with the rhomboid flap in the present study was 20x20 cm. There were no major wound complications and all patients underwent postoperative adjuvant therapy on schedule. During BCS, a portion of the flap was used for augmentation of the breast, in addition to coverage of the skin defect, which resulted in good cosmetic outcomes. The rhomboid flap can be quickly and easily fashioned, and it does not require any special instruments.

show abstract

The effectiveness of simultaneous oncoplastic breast surgery in patients with locally advanced breast cancer

Cited by 24 publications

References 30 publications

Early Wound Complications And Influencing Factors For The Breast Cancer Patients After Oncoplastic Surgery

Early Wound Complications And Influencing Factors For The Breast Cancer Patients After Oncoplastic Surgery

Oncoplastic Breast Surgery after Neoadjuvant Chemotherapy Replacing Mastectomy in Locally Advanced Breast Cancer (LABC): Single Institute Experience

Application of a rhomboid flap for the coverage of defects after malignant breast tumor resection: A case report

Contact Info

Product

Resources

About